These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31388072)

  • 21. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
    Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
    Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
    Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A
    PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon gamma release assays for diagnosis of osteoarticular tuberculosis: A systematic review and meta-analysis.
    Ren C; Tang J; Xia L
    PLoS One; 2022; 17(6):e0269234. PubMed ID: 35771875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
    Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
    Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular markers of tuberculosis and their clinical relevance: a systematic review and meta-analysis.
    Xu F; Ni M; Qu S; Duan Y; Zhang H; Qin Z
    Ann Palliat Med; 2022 Feb; 11(2):532-543. PubMed ID: 35249331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of interferon-gamma release assays for differentiating intestinal tuberculosis from Crohn's disease: a meta-analysis.
    Chen W; Fan JH; Luo W; Peng P; Su SB
    World J Gastroenterol; 2013 Nov; 19(44):8133-40. PubMed ID: 24307809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
    Amanatidou V; Critselis E; Trochoutsou A; Soldatou A; Benetatou K; Spyridis N; Papadopoulos NG; Tsolia MN
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1463-9. PubMed ID: 26614187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA.
    Nasiri MJ; Pormohammad A; Goudarzi H; Mardani M; Zamani S; Migliori GB; Sotgiu G
    Infection; 2019 Jun; 47(3):353-361. PubMed ID: 30805899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment.
    Yang Q; Cai Y; Zhao W; Wu F; Zhang M; Luo K; Zhang Y; Liu H; Zhou B; Kornfeld H; Chen X
    Clin Vaccine Immunol; 2014 Dec; 21(12):1635-44. PubMed ID: 25274803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
    Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
    PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis.
    Hong JY; Jung GS; Kim H; Kim YM; Lee HJ; Cho SN; Kim SK; Chang J; Kang YA
    Int J Infect Dis; 2012 Dec; 16(12):e855-9. PubMed ID: 22959355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis.
    Syed Ahamed Kabeer B; Raman B; Thomas A; Perumal V; Raja A
    PLoS One; 2010 Feb; 5(2):e9051. PubMed ID: 20140219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.